Eric Blair

Prof. Eric Blair

School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK
orcid

Research Focus & Metrics

Academic Career Length

55Years (1972-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1973 in Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis
Verified
Journal Article
Closed access
Eric BlairEric Blair
Eric Blair
RER.JOhn Ellis
R.JOhn Ellis

1 November 2010 in Analytica Chimica Acta
Verified
Journal Article
Closed access
RCRebecca L. Caygill
Rebecca L. Caygill
Eric BlairEric Blair
Eric Blair
PMPaul A. Millner
Paul A. Millner

1 January 1993 in Gastroenterology
Verified
Journal Article
Closed access
SBSandra M. Bell
Sandra M. Bell
NSNigel Scott
Nigel Scott
DCDebra Cross
Debra Cross
PSPeter Sagar
Peter Sagar
FLFraser A. Lewis
Fraser A. Lewis
PQPhilip Quirke
Philip Quirke

16 April 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
CWC. L. Wilson
C. L. Wilson
DJD. Jurk
D. Jurk
NFN. Fullard
N. Fullard
PBP. Banks
P. Banks
APA. Page
A. Page
DMDerek A Mann
Derek A Mann
Hepatocellular carcinoma (HCC) develops on the background of chronic hepatitis. Leukocytes found within the HCC microenvironment are implicated as regulators of tumour growth. We show that diethylnitrosamine (DEN)-induced murine HCC is attenuated by antibody-mediated depletion of hepatic neutrophils, the latter stimulating hepatocellular ROS and telomere DNA damage. We additionally report a previously unappreciated tumour suppressor function for hepatocellular nfkb1 operating via p50:p50 dimers and the co-repressor HDAC1. These anti-inflammatory proteins combine to transcriptionally repress hepatic expression of a S100A8/9, CXCL1 and CXCL2 neutrophil chemokine network. Loss of nfkb1 promotes ageing-associated chronic liver disease (CLD), characterized by steatosis, neutrophillia, fibrosis, hepatocyte telomere damage and HCC. Nfkb1S340A/S340Amice carrying a mutation designed to selectively disrupt p50:p50:HDAC1 complexes are more susceptible to HCC; by contrast, mice lacking S100A9 express reduced neutrophil chemokines and are protected from HCC. Inhibiting neutrophil accumulation in CLD or targeting their tumour-promoting activities may offer therapeutic opportunities in HCC.

1 April 2000 in Immunology & Cell Biology
Verified
Journal Article
Closed access
LSLuke H Stockwin
Luke H Stockwin
DMDennis McGonagle
Dennis McGonagle
IMIain G Martin
Iain G Martin
Eric BlairEric Blair
Eric Blair

1 August 2001 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
IPI.R. Poxton
I.R. Poxton
JMJ. McCoubrey
J. McCoubrey
Eric BlairEric Blair
Eric Blair